Tranexamic acid group (n=80) | Placebo group (n=80) | P value | |
---|---|---|---|
Estimated blood loss (mL)b | 583.23 ± 379.62 | 896.81 ± 519.6 | <0.001 |
Hemoglobin concentration (g/dL) | |||
Preoperative | 10.9 ± 1.1 | 11.0 ± 1.0 | 0.852 |
Postoperative | 10.1 ± 1.2 | 9.2 ± 1.6 | <0.001 |
Percentage change | 7.34 (1.4–18.34) | 16.36 (7.5–25.7) | <0.001 |
Hematocrit % | |||
Preoperative | 32.8 ± 3.2 | 33.1 ± 3.0 | 0.662 |
Postoperative | 30.1 ± 3.4 | 27.4 ± 4.1 | 0.012 |
Percentage change | 7.11 (2.7–19.87) | 15.41 (6.9–27.1) | <0.001 |
Need for further ecbolics | 11 (13.75%) | 37 (46.25%) | <0.001 |
Need for intraoperative blood transfusion | 1 (1.25%) | 5 (6.25%) | 0.071 |